Comparative Pharmacology
Head-to-head clinical analysis: TINIDAZOLE versus VANDAZOLE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TINIDAZOLE versus VANDAZOLE.
TINIDAZOLE vs VANDAZOLE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Tinidazole is a nitroimidazole antibiotic that diffuses into microorganisms where it is reduced by bacterial nitroreductases to form reactive cytotoxic intermediates that damage DNA and inhibit protein synthesis, leading to cell death. It is active against anaerobic bacteria and protozoa.
VANDAZOLE is a nitroimidazole antimicrobial agent that undergoes reduction by bacterial nitroreductases, forming cytotoxic free radicals that damage DNA and inhibit nucleic acid synthesis.
2 g orally once daily for 2 days; alternatively, 1 g orally once daily for 5 days for trichomoniasis. For bacterial vaginosis: 2 g orally once daily for 2 days. For giardiasis: 2 g orally as a single dose. For amebiasis: 2 g orally once daily for 3 days for intestinal amebiasis; 2 g orally once daily for 5 days for hepatic amebiasis.
2 g orally as a single dose once daily for 2 days.
None Documented
None Documented
Clinical Note
moderateTinidazole + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Tinidazole."
Clinical Note
moderateTinidazole + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Tinidazole."
Clinical Note
moderateTinidazole + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Tinidazole."
Clinical Note
moderateTinidazole + Fluconazole
The terminal elimination half-life is approximately 12-14 hours in healthy adults, which supports once-daily dosing. In hepatic impairment, half-life may be prolonged.
Approximately 8-10 hours in adults; prolonged to 20-25 hours in hepatic impairment.
Following oral administration, approximately 20-25% of the dose is excreted unchanged in urine, with an additional 10-15% as metabolites. Fecal excretion accounts for about 50% of the dose, primarily as metabolites. Biliary excretion is a minor route.
Primarily renal (40-70% unchanged), with biliary/fecal elimination accounting for 15-20% as metabolites.
Category A/B
Category C
Nitroimidazole Antibiotic
Nitroimidazole Antibiotic
"The metabolism of Fluconazole can be decreased when combined with Tinidazole."